SECSONAR

$CAI

Caris Life Sciences, Inc.

NASDAQ

Director bought $501K

Up 13% since last report

53% below 52-week high

Insider cost basis

Insiders bought — stock holding above

+13.4%vs buy

Insider buy $16.15Now $18.32

Find before everyone else

SEC filings, insider trades & earnings for CAI — in one place.